EZBrisk / Market Verdict

DHR raises EPS guide

Danaher's adjusted EPS beat and full-year guidance moved higher, while revenue came in slightly below consensus and core growth accelerated excluding respiratory.

Sources: https://www.sec.gov/Archives/edgar/data/313616/000031361626000201/dhr-20261021xex991.htm

Previous verdicts for DHR

Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works

Open the live Ezbrisk dashboard Browse the archive